0001144204-19-000503.txt : 20190103 0001144204-19-000503.hdr.sgml : 20190103 20190103190436 ACCESSION NUMBER: 0001144204-19-000503 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190101 FILED AS OF DATE: 20190103 DATE AS OF CHANGE: 20190103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weyer Christian CENTRAL INDEX KEY: 0001493811 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35668 FILM NUMBER: 19507777 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001270073 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223868459 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 HUDSON YARDS, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 646-747-1000 MAIL ADDRESS: STREET 1: 10 HUDSON YARDS, 37TH FLOOR CITY: New York STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20031113 4 1 tv510195_form4.xml FORM 4 X0306 4 2019-01-01 0 0001270073 INTERCEPT PHARMACEUTICALS, INC. ICPT 0001493811 Weyer Christian C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, FLOOR 37 NEW YORK NY 10001 0 1 0 0 EVP, Research & Development Common Stock 2019-01-01 4 F 0 215 100.79 D 15604 D Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock units. /s/ John C. Duncanson, as attorney-in-fact 2019-01-03